Showing results (591-600 of 3,868) with videos related to
Sort By:
Pageof 387
Cancer Biology & Therapy|April 16, 2019
Knockdown of lncRNA LEF1-AS1 inhibited the progression of oral squamous cell carcinoma (OSCC) via Hippo signaling pathwayChanqiong Zhang, Chunchun Bao, Xiuxing Zhang, et al.Cancer Biology & Therapy|April 16, 2019
MiR-202-5p/PTEN mediates doxorubicin-resistance of breast cancer cells via PI3K/Akt signaling pathwayTao Liu, Jichao Guo, Xiaoxia ZhangCancer Biology & Therapy|October 12, 2018
The histone deacetylase inhibitor Suberoylanilide Hydroxamic Acid (SAHA) as a therapeutic agent in rhabdomyosarcomaSandra E Ghayad, Ghina Rammal, Omar Sarkis, et al.Cancer Biology & Therapy|October 3, 2018
Sorafenib inhibits caspase-1 expression through suppressing TLR4/stat3/SUMO1 pathway in hepatocellular carcinomaJun Li, Yuan Zhou, Yang Liu, et al.Cancer Biology & Therapy|October 3, 2018
Loss of lipid phosphatase SHIP1 promotes macrophage differentiation through suppression of dendritic cell differentiationEui Young So, Changqi Sun, Anthony M Reginato, et al.Cancer Biology & Therapy|August 16, 2018
Successful maintenance therapy with apatinib inplatinum-resistant advanced ovarian cancer and literature reviewMin Jin, Jun Cai, Xuan Wang, et al.Cancer Biology & Therapy|May 6, 2017
DNA repair genes PAXIP1 and TP53BP1 expression is associated with breast cancer prognosisGiuliana De Gregoriis, Juliene Antonio Ramos, Priscila Valverde Fernandes, et al.Cancer Biology & Therapy|May 6, 2017
The codon 72 polymorphism of p53 influences cell fate following nutrient deprivationChe-Pei Kung, Qin Liu, Maureen E MurphyCancer Biology & Therapy|May 6, 2017
Vandetanib and cabozantinib potentiate mitochondria-targeted agents to suppress medullary thyroid carcinoma cellsDmytro Starenki, Seung-Keun Hong, Pui-Kei Wu, et al.Cancer Biology & Therapy|July 6, 2017
Successful treatment of advanced pancreatic liposarcoma with apatinib: A case report and literature reviewTao Han, Yuting Luan, Ying Xu, et al.Pageof 387